|
Preventing Depression in Patients with Macular Degeneration Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Preventing Depression in Patients with Macular Degeneration conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Preventing Depression in Patients with Macular Degeneration Clinical research trials and Preventing Depression in Patients with Macular Degeneration medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Preventing Depression in Patients with Macular Degeneration. Preventing Depression in Patients with Macular Degeneration Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Preventing Depression in Patients with Macular Degeneration clinical trial. Subjects often receive the most expert healthcare possible for their Preventing Depression in Patients with Macular Degeneration condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Preventing Depression in Patients with Macular Degeneration  Preventing Depression in Patients with Macular Degeneration
Preventing Depression in Patients with Macular Degeneration
For Condition: Depression,Macular Degeneration
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to evaluate the efficacy of a brief, standardized cognitive psychotherapy called Problem Solving Treatment (PST) to prevent depression in elderly patients with age-related macular degeneration (AMD).
Details: AMD is the most common cause of blindness in older adults. The disease limits the ability to read, see familiar faces, and walk independently. Almost 2 million persons (about 5 percent of the U.S. population over age 65) are now affected, and this number will triple by the year 2020. This study will target patients with neovascular AMD (NV-AMD), a form of AMD which can lead to sudden vision loss, substantial disability, and depression. Because depression is itself disabling and not likely to be recognized nor treated by ophthalmologists, preventing depression in people with NV-AMD is important. Patients are randomly assigned to either PST or a usual care control condition. The primary outcome measure is a DSM-IV diagnosis of depression. Patients are evaluated at baseline, Month 2 (immediately post-intervention), Month 6 (for the primary efficacy analysis), and Month 12 (to evaluate sustained effects). The study will also assess the impact of PST on levels of disability and vision-related quality of life.
Eligibility:
Study Type: Interventional, Prevention, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 65 Years/
Genders: Both
Protocol Entry Criteria: Inclusion criteria: - Bilateral macular degeneration - Visual acuity of 20/40 or worse in better eye - Residence within 40 miles of Wills Eye Hospital in Philadelphia, PA
Total Enrollment: 230
Location and Contact Information:
Jefferson Medical College and Wills Eye Hospital *Recruiting*
Philadelphia, Pennsylvania, 19107
United States
Recruiting Robin Casten 215-503-1250
Additional Information:
Study ID Numbers: 61331-01A1;
Study Start Date: February 2001
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00042211
Other Depression Studies:
1. Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders
2. Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy
3. Identification and Treatment of Feeder Vessels in Macular Degeneration
4. Preventing Depression in Patients with Macular Degeneration
5. Lutein for Age-Related Macular Degeneration
Related Studies:
Other Depression Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials
Preventing Depression in Patients with Macular Degeneration
|
|
|
|
|
|
|
|
